Drug Name: Inpefa

Indications: To treat heart failure.

Active Ingredient: Sotagliflozin

Company: Lexicon Pharmaceuticals, Inc

Approval Date: 5/26/2023

More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216203s000lbl.pdf